MeVis Medical Solutions AG (M3V):企業の財務・戦略的SWOT分析

◆英語タイトル:MeVis Medical Solutions AG (M3V) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14211
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

MeVis Medical Solutions AG (M3V) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

MeVis Medical Solutions AG (MMS AG), a subsidiary of Varex Imaging Corp, is a medical technology company. It develops and markets software to analyze and evaluate image data to medical device equipment manufacturers and providers of medical IT platforms. The company’s software solutions are used in screening, diagnostics, therapy and intervention planning for breast, lung, colon, and prostate cancers; and neurological disorders. Its solutions portfolio includes industrial solutions; and professional solutions such as MeVis Distant services, MeVis online academy and Veolity. The company operates its Digital Mammography business through joint venture, MeVis BreastCare GmbH & Co. KG. MMS AG is headquartered in Bremen, Germany.

MeVis Medical Solutions AG Key Recent Developments

Aug 21,2018: MeVis Medical Solutions announces third quarter of fiscal year results
May 15,2018: MeVis publishes figures for the second quarter of fiscal year 2017/2018
Feb 20,2018: MeVis publishes figures for the first quarter of fiscal year 2017/2018
Jan 23,2018: MeVis publishes Revenue Of €18.5 Million In The First Nine Months Of 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
MeVis Medical Solutions AG – Key Facts
MeVis Medical Solutions AG – Key Employees
MeVis Medical Solutions AG – Key Employee Biographies
MeVis Medical Solutions AG – Major Products and Services
MeVis Medical Solutions AG – History
MeVis Medical Solutions AG – Company Statement
MeVis Medical Solutions AG – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
MeVis Medical Solutions AG – Business Description
Business Segment: Development Services
Overview
Performance
Business Segment: Digital Mammography
Overview
Performance
Business Segment: Other Operating Activities
Overview
Performance
Geographical Segment: Europe
Performance
Geographical Segment: The US
Performance
R&D Overview
MeVis Medical Solutions AG – SWOT Analysis
SWOT Analysis – Overview
MeVis Medical Solutions AG – Strengths
MeVis Medical Solutions AG – Weaknesses
MeVis Medical Solutions AG – Opportunities
MeVis Medical Solutions AG – Threats
MeVis Medical Solutions AG – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
MeVis Medical Solutions AG, Medical Equipment, Deals By Year, 2013 to YTD 2019
MeVis Medical Solutions AG, Medical Equipment, Deals By Type, 2013 to YTD 2019
MeVis Medical Solutions AG, Recent Deals Summary
Section 5 – Company’s Recent Developments
Aug 21, 2018: MeVis Medical Solutions announces third quarter of fiscal year results
May 15, 2018: MeVis publishes figures for the second quarter of fiscal year 2017/2018
Feb 20, 2018: MeVis publishes figures for the first quarter of fiscal year 2017/2018
Jan 23, 2018: MeVis publishes Revenue Of €18.5 Million In The First Nine Months Of 2017
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
MeVis Medical Solutions AG, Key Facts
MeVis Medical Solutions AG, Key Employees
MeVis Medical Solutions AG, Key Employee Biographies
MeVis Medical Solutions AG, Major Products and Services
MeVis Medical Solutions AG, History
MeVis Medical Solutions AG, Joint Venture
MeVis Medical Solutions AG, Key Competitors
MeVis Medical Solutions AG, Ratios based on current share price
MeVis Medical Solutions AG, Annual Ratios
MeVis Medical Solutions AG, Annual Ratios (Cont...1)
MeVis Medical Solutions AG, Annual Ratios (Cont...2)
MeVis Medical Solutions AG, Interim Ratios
MeVis Medical Solutions AG, Medical Equipment, Deals By Year, 2013 to YTD 2019
MeVis Medical Solutions AG, Medical Equipment, Deals By Type, 2013 to YTD 2019
MeVis Medical Solutions AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
MeVis Medical Solutions AG, Performance Chart (2014 - 2018)
MeVis Medical Solutions AG, Ratio Charts
MeVis Medical Solutions AG, Medical Equipment, Deals By Year, 2013 to YTD 2019
MeVis Medical Solutions AG, Medical Equipment, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[MeVis Medical Solutions AG (M3V):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The National Commercial Bank:企業の戦略・SWOT・財務情報
    The National Commercial Bank - Strategy, SWOT and Corporate Finance Report Summary The National Commercial Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Philip Morris International Inc (PM):企業の財務・戦略的SWOT分析
    Philip Morris International Inc (PM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Stilo International Plc (STL):企業の財務・戦略的SWOT分析
    Summary Stilo International plc (Stilo) operates as a technology company that offers cloud content solutions. The company’s products include developer tools, XML cloud conversion and SME authoring. It offers digital content and publishes information to multiple channels such as print, web, CD-ROM, s …
  • National Railroad Passenger Corporation:企業の戦略・SWOT・財務情報
    National Railroad Passenger Corporation - Strategy, SWOT and Corporate Finance Report Summary National Railroad Passenger Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Overseas Shipholding Group Inc (OSG):企業の財務・戦略的SWOT分析
    Overseas Shipholding Group Inc (OSG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Virtus Investment Partners, Inc.:企業の戦略・SWOT・財務分析
    Virtus Investment Partners, Inc. - Strategy, SWOT and Corporate Finance Report Summary Virtus Investment Partners, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Prexton Therapeutics SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Prexton Therapeutics SA (Prexton) is a developer of drugs for Parkinson’s disease and other brain disorders. The company designs and develops mGluR4 positive allosteric modulator compounds for the treatment for Parkinson’s disease. It also develops positive allosteric modulators, or PAMs to …
  • U.S. National Geospatial-Intelligence Agency:企業の戦略的SWOT分析
    U.S. National Geospatial-Intelligence Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Teledyne Technologies Inc (TDY):企業の財務・戦略的SWOT分析
    Teledyne Technologies Inc (TDY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Inotek Pharmaceuticals Corp (RCKT):製薬・医療:M&Aディール及び事業提携情報
    Summary Inotek Pharmaceuticals Corp (IPC) is a clinical-stage biopharmaceutical company that focus on the discovery and development of novel therapeutics for the treatment of glaucoma and serious diseases of the eye. The company’s trabodenoson is a selective adenosine mimetic that stimulates a speci …
  • Warner Music Group Corp:企業の戦略的SWOT分析
    Warner Music Group Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Aetna Inc:企業のM&A・事業提携・投資動向
    Aetna Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Aetna Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Ilana Jivago Inc.:企業の戦略・SWOT・財務情報
    Ilana Jivago Inc. - Strategy, SWOT and Corporate Finance Report Summary Ilana Jivago Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Matthews International Corp (MATW):企業の財務・戦略的SWOT分析
    Matthews International Corp (MATW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Northland Power Inc (NPI):電力:M&Aディール及び事業提携情報
    Summary Northland Power Inc. (Northland Power) is an independent power producer that develops, finances, builds, owns, and operates clean and green power projects in Canada and internationally. The company generates energy from natural gas, biomass, landfill gas, wind and solar sources. In thermal g …
  • AGILeBiotics BV:製薬・医療:M&Aディール及び事業提携情報
    Summary AGILeBiotics BV (AGILeBiotics) is a pharmaceutical company that focus on the discovery and development of new antibiotics to treat multi-drug resistant infections. The company’s patented synthetic method technology OxaSelect transforms the currently available antibiotics, which became less e …
  • Jefferies Group LLC:企業のM&A・事業提携・投資動向
    Jefferies Group LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Jefferies Group LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Akzo Nobel N.V.:企業の戦略・SWOT・財務情報
    Akzo Nobel N.V. - Strategy, SWOT and Corporate Finance Report Summary Akzo Nobel N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Takuma Co Ltd (6013):企業の財務・戦略的SWOT分析
    Takuma Co Ltd (6013) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Micronics Inc:企業の製品パイプライン分析2018
    Summary Micronics Inc (Micronics) is a medical device company that develops and markets in vitro diagnostic products. The company provides products that include aborhcard and pannat system. Its research and development products comprise single-use, stand alone, disposable microfluidics-enabled cartr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆